Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE

(WBA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Walgreens Boots Alliance : Sales Growth Falls Short--Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 08:33am EDT

By Kimberly Chin

Walgreens Boots Alliance Inc.'s shares slid in premarket trading as weaker sales of non-pharmacy items put a damper on the drugstore chain's sales growth.

Comparable retail sales in the fourth quarter fell 1.9% from a year earlier in the U.S., weighed by less demand in the general-merchandise and personal-care categories. Comparable retail sales in its international segment fell 0.9% on a constant-currency basis.

Overall sales rose 11% to $33.44 billion, as growth in prescription volumes helped lift pharmacy sales. Walgreens said U.S. pharmacy sales rose 17%, due primarily to its acquisition of stores from Rite Aid Corp. Thursday, the company said the integration remains on track and has helped it gain market share. Analysts had expected Walgreens to report $33.78 billion in revenue, according to a Refinitiv poll.

Shares fell 2.5% to $70.51. Walgreens stock has been flat for the year.

Net income for the Deerfield, Ill.-based company rose 89% to $1.51 billion, or $1.55 a share, from the same period a year ago. On an adjusted basis, earnings per share came in at $1.48, above the $1.45 expected by analysts.

The drugstore chain also gave earnings guidance for the fiscal year 2019. It expects earnings growth between 7% to 12% at constant-currency rates, and adjusted earnings per share in the range of $6.40 to $6.70. Analysts expect adjusted earnings of $6.45 a share.

The company, whose roots date to 1901, has more than 18,500 stores across 11 countries.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
WALGREENS BOOTS ALLIANCE -0.61% 52.57 Delayed Quote.-22.60%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
06/12U.S. pet doctors steel themselves for online pharmacy challenge
RE
06/11Kroger to start selling cannabis-based products
RE
06/11Kroger to start selling cannabis-based products
AQ
06/04CVS HEALTH : At stores and online, health care moves closer to customers
AQ
06/03WALGREENS BOOTS ALLIANCE : Schedules Fiscal 2019 Third Quarter Earnings Announce..
BU
05/21KROGER : Loop Launches in U.S., Announces Kroger and Walgreens as Founding Retai..
DJ
05/17WALGREENS BOOTS ALLIANCE : Ex-dividend day for
FA
05/13WALGREENS BOOTS ALLIANCE : Announces Collaboration for Cancer Prevention, Resear..
BU
05/08Walmart raises U.S. tobacco purchase age to 21 starting in July
RE
05/02WALGREENS BOOTS ALLIANCE : Texas Markets Top Walgreens Flu™ Index for Over..
BU
More news
Financials ($)
Sales 2019 137 B
EBIT 2019 7 185 M
Net income 2019 4 581 M
Debt 2019 14 957 M
Yield 2019 3,46%
P/E ratio 2019 10,26
P/E ratio 2020 9,59
EV / Sales 2019 0,46x
EV / Sales 2020 0,43x
Capitalization 47 516 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 57,9 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
Richard M. Ashworth President-Operations
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE-22.60%45 633
MCKESSON CORPORATION20.51%23 662
AMERISOURCEBERGEN14.31%16 892
CARDINAL HEALTH-0.99%12 793
SINOPHARM HOLDING CO LTD-17.02%11 235
SHANGHAI PHARMACEUTICALS HOLDING CO LTD4.12%6 953